M. V. Pimm

3.1k total citations
123 papers, 2.3k citations indexed

About

M. V. Pimm is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, M. V. Pimm has authored 123 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Radiology, Nuclear Medicine and Imaging, 35 papers in Molecular Biology and 35 papers in Oncology. Recurrent topics in M. V. Pimm's work include Monoclonal and Polyclonal Antibodies Research (48 papers), Radiopharmaceutical Chemistry and Applications (47 papers) and Cancer Research and Treatments (18 papers). M. V. Pimm is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (48 papers), Radiopharmaceutical Chemistry and Applications (47 papers) and Cancer Research and Treatments (18 papers). M. V. Pimm collaborates with scholars based in United Kingdom, Hungary and United States. M. V. Pimm's co-authors include R W Baldwin, Alan C. Perkins, Robert W. Baldwin, M. J. Embleton, J D Hardcastle, Ferenc Hudecz, P A Farrands, J. A. Clegg, Nicholas Armitage and Karel Ulbrich and has published in prestigious journals such as Nature, The Lancet and JNCI Journal of the National Cancer Institute.

In The Last Decade

M. V. Pimm

118 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. V. Pimm United Kingdom	29	1.2k	769	682	659	272	123	2.3k
Agamemnon A. Epenetos United Kingdom	30	1.4k 1.2×	1.1k 1.4×	665 1.0×	407 0.6×	134 0.5×	84	2.5k
Robert Waibel Switzerland	27	1.6k 1.3×	1.2k 1.6×	862 1.3×	459 0.7×	222 0.8×	78	3.0k
M. J. Embleton United Kingdom	30	1.3k 1.1×	1.4k 1.8×	806 1.2×	1.1k 1.7×	227 0.8×	82	2.8k
K D Bagshawe United Kingdom	27	890 0.7×	940 1.2×	508 0.7×	251 0.4×	206 0.8×	96	2.5k
M. Jules Mattes United States	35	1.9k 1.6×	1.0k 1.3×	755 1.1×	912 1.4×	87 0.3×	94	3.2k
Jean‐Pierre Mach Switzerland	32	1.9k 1.6×	1.3k 1.6×	1.2k 1.7×	944 1.4×	101 0.4×	67	3.3k
Richard M. Bartholomew United States	28	1.2k 1.0×	1.1k 1.4×	563 0.8×	895 1.4×	126 0.5×	64	2.8k
Clay B. Siegall United States	27	1.4k 1.2×	1.2k 1.5×	1.5k 2.1×	1.2k 1.9×	683 2.5×	60	3.4k
Vincent R. Zurawski United States	28	761 0.6×	1.0k 1.3×	537 0.8×	677 1.0×	82 0.3×	44	3.2k
Susan L. Deutscher United States	30	1.4k 1.2×	2.2k 2.8×	594 0.9×	866 1.3×	117 0.4×	83	3.6k

Countries citing papers authored by M. V. Pimm

Since Specialization

Citations

This map shows the geographic impact of M. V. Pimm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. V. Pimm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. V. Pimm more than expected).

Fields of papers citing papers by M. V. Pimm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. V. Pimm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. V. Pimm. The network helps show where M. V. Pimm may publish in the future.

Co-authorship network of co-authors of M. V. Pimm

This figure shows the co-authorship network connecting the top 25 collaborators of M. V. Pimm. A scholar is included among the top collaborators of M. V. Pimm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. V. Pimm. M. V. Pimm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frier, M., Alan C. Perkins, M. V. Pimm, & Ferenc Hudecz. (1995). Genetically engineered and synthetic macromolecules as radiophameceuticals with potential for liver, lung, blood pool and tumor imaging. Nuclear Medicine Communications. 16(4). 240–240. 1 indexed citations

Pimm, M. V., et al.. (1994). Prevention of renal tubule re-absorption of radiometal (indium-111) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine. European Journal of Nuclear Medicine and Molecular Imaging. 21(7). 663–665. 40 indexed citations

Pimm, M. V., et al.. (1994). Effect of systemic DTPA treatment on tissue retention of free and carrier-bound 111in from labelled proteins and polymer. Nuclear Medicine and Biology. 21(6). 889–892. 1 indexed citations

Awang, Mohamed, John G. Hardy, S.S. Davis, et al.. (1994). Evaluation of 153Sm-diethylenetriaminepentaacetic acid for radiolabelling of pharmaceutical dosage forms by neutron activation. Nuclear Medicine and Biology. 21(7). 905–909. 4 indexed citations

Pimm, M. V.. (1994). Possible consequences of human antibody responses on the biodistribution of fragments of human, humanized or chimeric monoclonal antibodies: A note of caution. Life Sciences. 55(2). PL45–PL49. 12 indexed citations

Pimm, M. V., et al.. (1993). Influence of syngeneic monoclonal anti-idiotypic antibodies to murine monoclonal antibodies against tumour-associated antigens on the biodistribution of their target antibodies and their fragments. Journal of Cancer Research and Clinical Oncology. 119(7). 408–414. 3 indexed citations

Pimm, M. V., et al.. (1992). Toxicity associated with the formation and clearance of immune complexes between antitumour monoclonal antibodies and syngeneic anti-idiotypic antibodies in mice. Journal of Cancer Research and Clinical Oncology. 119(1). 41–45. 4 indexed citations

Pimm, M. V., et al.. (1992). Evaluation of monoclonal idiotypic-specific antibodies as clearing antibodies for enhancement of target localisation by tumour-specific monoclonal antibodies: diversity of effects in nude mice with human tumour xenografts. European Journal of Nuclear Medicine and Molecular Imaging. 19(6). 436–40. 3 indexed citations

Perkins, Alan C. & M. V. Pimm. (1991). Immunoscintigraphy : practical aspects and clinical applications. 15 indexed citations

10.

Demignot, Sylvie, et al.. (1991). Differences between the catabolism and tumour distribution of intact monoclonal antibody (791T/36) and its Fab/c fragment in mice with tumour xenografts revealed by the use of a residualizing radiolabel (dilactitol-125I-tyramine) and autoradiography. Cancer Immunology Immunotherapy. 33(6). 359–366. 10 indexed citations

11.

Pimm, M. V. & Teresa Morris. (1990). Growth rates on human tumors in nude mice. European Journal of Cancer. 26(6). 764–765.

12.

Pimm, M. V., et al.. (1990). Mouse-specific antibody responses to a monoclonal antibody during repeated immunoscintigraphy investigations: Comparison of antibody titres and imaging studies in a rat model. European Journal of Nuclear Medicine and Molecular Imaging. 17(5). 216–222.

13.

Pimm, M. V. & R W Baldwin. (1990). Syngeneic anti-idiotypic antibody prevents localization of a murine monoclonal antibody in human tumour xenografts. European Journal of Cancer and Clinical Oncology. 26(5). 567–568. 11 indexed citations

14.

Pimm, M. V., Lindy G. Durrant, & R W Baldwin. (1989). The influence of syngeneic anti‐idiotypic antibody on the biodistribution of an anti‐tumour monoclonal antibody in balb/c mice. International Journal of Cancer. 43(1). 147–151. 10 indexed citations

15.

Pimm, M. V., Sarah M. Andrew, & R W Baldwin. (1989). Blood and tissue kinetics of radiolabeled anti-CEA monoclonal antibody and F(ab)2 and Fab fragments in nude mice with human tumour xenografts. Nuclear Medicine Communications. 10(8). 585–594. 7 indexed citations

16.

Pimm, M. V., et al.. (1988). Iodine-131 and indium-111 labelled avidin and streptavidin for pre-targetted immunoscintigraphy with biotinylated anti-tumour monoclonal antibody. Nuclear Medicine Communications. 9(11). 931–931. 31 indexed citations

17.

Pimm, M. V., J. A. Clegg, Martin C. Garnett, & R W Baldwin. (1988). Biodistribution and tumour localization of a methotrexate‐monoclonal‐antibody 791T/36 conjugate in nude mice with human tumour xenografts. International Journal of Cancer. 41(6). 886–891. 18 indexed citations

18.

Pimm, M. V. & R W Baldwin. (1987). Comparative biodistributions and rates of catabolism of radiolabelled anti-CEA monoclonal antibody and control immunoglobulin in nude mice with human tumour xenografts showing specific antibody localization. European Journal of Nuclear Medicine and Molecular Imaging. 13(5). 258–63. 5 indexed citations

19.

Pimm, M. V., J. A. Clegg, & R W Baldwin. (1987). Biodistribution and tumour localization of radiolabelled monoclonal antibody during continuous infusion in nude mice and with human tumour xenografts. European Journal of Cancer and Clinical Oncology. 23(5). 521–527. 15 indexed citations

20.

Pimm, M. V., et al.. (1987). Biodistribution of methotrexate-monoclonal antibody conjugates and complexes: experimental and clinical studies. Cancer Treatment Reviews. 14(3-4). 411–420. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact